SCHEMBL31676089

SCHEMBL31676089

C[C@@H](Oc1nc(-c2ccn(C)c2)cc2ncccc12)[C@@H]1CNCC(C)(C)O1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31676102 1.00 SYK (0.47) SYK
SCHEMBL31676434 0.88 SYK (0.47) SYK
SCHEMBL30613617 0.85 SYK (0.49) SYK
SCHEMBL31676119 0.85 SYK (0.47) SYK
SCHEMBL31676438 0.85 SYK (0.47) SYK
SCHEMBL30613728 0.83 SYK (0.47) SYK
SCHEMBL31335129 0.77 SYK (0.47) SYK
SCHEMBL31676068 0.77 SYK (0.47) SYK
SCHEMBL31676485 0.77 SYK (0.47) SYK
SCHEMBL31676442 0.76 SYK (0.46) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263408-A1 SPLEEN TYROSINE KINASE INHIBITORS UNIQUEST PTY LTD (AU) 2025-08-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263408-A1 SPLEEN TYROSINE KINASE INHIBITORS LCK, BTK, SYK SYK 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback